drugset / Trial / NCT00006043

Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin

NCT00006043 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have metastatic germ cell tumors that have not responded to cisplatin.

Timeline

Start
2000-02
Primary completion
2001-11
Completion
2001-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral